USPTO 2015–2025 USPTO PatentsView US Corporation

Rotation Medical, Inc.

USPTO PatentsView assignee record - 85 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Rotation ranks #4,218 of 49,997 tracked US assignees by granted-patent volume, with 85 patents across 5 technology areas.

#4,218
of 49,997 US assignees by volume
Top 43%
by Innovation Score (37.5/100)
17.8
avg claims per patent
-24%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4218 · US Corporation #4,218 · 85 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 85 grants
  • TOP-DECILE #4,218/49,997
  • PHOTO-FINISH Omrix Biopharmaceuti…
  • CPC-NARROW A61F · 5 areas
  • INNOV-THIN 37.5/100
  • CLAIMS-RICH 17.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -24% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Omrix Biopharmaceuticals Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Rotation

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Rotation's Innovation Score is 37.5/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Rotation's grants concentrate

Rotation Medical, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 83.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (13 grants) versus a trough of 3 in 2017. By volume, Rotation sits between Omrix Biopharmaceuticals Ltd. and Solum Co., Ltd..

Rotation's three-year grant acceleration

From 2019–2021 to 2022–2024, Rotation Medical, Inc. moved from 28 to 15 grants (0.54x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Rotation's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Rotation holds 85 patents at rank #4,218, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Rotation

By rank, the assignees closest to #4,218 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Rotation's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rotation, neither rank-band nor same-CPC leaders (those blocks stay above).

Rotation's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20152016201720182019202020212022202320242025 6
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Rotation Medical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 13 15.3%
2016 9 10.6%
2017 3 3.5%
2018 11 12.9%
2019 9 10.6%
2020 8 9.4%
2021 11 12.9%
2022 5 5.9%
2023 5 5.9%
2024 5 5.9%
2025partial year 6 7.1%

Where it ranks

Overall rank by patents

#4,218

of 49,997 tracked assignees

Innovation Score

37.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Rotation Medical, Inc.'s patent record in context - here's where to go next.

  • Rotation Medical, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 83.5% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #4,218 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Rotation Medical, Inc. against Omrix Biopharmaceuticals Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.